SFG
ADPT icon

Steward Financial Group’s Adaptive Biotechnologies ADPT Stock Holding History

Steward Financial Group’s Portfolio ADPT Stock Details ADPT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q1 		– Sell
-1,600
Closed -$12K – 696
2022
Q4 		$12K Buy
+1,600
New +$12.4K 0.01% 132
2022
Q3 		– Sell
-1,600
Closed -$12K – 74
2022
Q2 		$12K Hold
1,600
– – 0.01% 212
2022
Q1 		$22K Hold
1,600
– – 0.02% 149
2021
Q4 		$44K Buy
+1,600
New +$49K 0.04% 77

Other funds holding ADPT

Viking Global Investors
Viking Global Investors Stamford, Connecticut $35.7B AUM 21.3% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
MCMC
Matrix Capital Management Company Portsmouth, New Hampshire $46.3M AUM 114.38% 1-Year Est. Return
AIM
ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return
Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $154B AUM 29.96% 1-Year Est. Return
NAMA
Nikko Asset Management Americas New York $7.07B AUM 50.91% 1-Year Est. Return
BWLSA
Blue Water Life Science Advisors Larkspur, California $125M AUM 91.82% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return

Steward Financial Group's ADPT Position: Q1 2023 in Review

Steward Financial Group sold out of Adaptive Biotechnologies (ADPT) in Q1 2023, closing a stake of 1,600 shares — an estimated $12K sold.

Steward Financial Group first reported a position in ADPT in Q4 2021 and held it in 4 quarters. The position peaked at $44K in Q4 2021. 226 funds tracked by Wall St. Rank hold ADPT as of Q1 2023.

  • Steward Financial Group reported no remaining Adaptive Biotechnologies position as of Q1 2023 after selling out during the quarter.
  • Steward Financial Group sold 1,600 Adaptive Biotechnologies shares in Q1 2023, an estimated $12K.
  • Steward Financial Group first reported a position in Adaptive Biotechnologies in Q4 2021 and held it in 4 quarters.
  • Steward Financial Group's Adaptive Biotechnologies position peaked at $44K in Q4 2021.
  • 226 funds tracked by Wall St. Rank held Adaptive Biotechnologies as of Q1 2023.

Based on Steward Financial Group's 13F filing for Q1 2023, filed 5 May 2023.